For research use only. Not for therapeutic Use.
Relamorelin TFA（Cat No.:I045084）is a synthetic pentapeptide and potent ghrelin receptor agonist primarily investigated for treating diabetic gastroparesis and gastrointestinal motility disorders. It mimics the action of ghrelin to stimulate gastric emptying and improve GI function. Relamorelin demonstrates enhanced stability and bioavailability compared to natural ghrelin, making it a promising candidate for clinical use. The TFA salt form improves solubility and handling. Research also explores its potential in appetite regulation and cachexia. It is available at high purity for laboratory research focused on metabolic and gastrointestinal health applications.
| CAS Number | 2863659-22-5 |
| Synonyms | 4-[[(2S)-2-[[(2R)-2-[[(2R)-3-(1-benzothiophen-3-yl)-2-(piperidine-4-carbonylamino)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]piperidine-4-carboxamide;2,2,2-trifluoroacetic acid |
| Molecular Formula | C45H51F3N8O7S |
| Purity | ≥95% |
| IUPAC Name | 4-[[(2S)-2-[[(2R)-2-[[(2R)-3-(1-benzothiophen-3-yl)-2-(piperidine-4-carbonylamino)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]piperidine-4-carboxamide;2,2,2-trifluoroacetic acid |
| InChI | InChI=1S/C43H50N8O5S.C2HF3O2/c44-42(56)43(16-20-46-21-17-43)51-41(55)34(22-27-8-2-1-3-9-27)49-39(53)35(23-29-25-47-33-12-6-4-10-31(29)33)50-40(54)36(48-38(52)28-14-18-45-19-15-28)24-30-26-57-37-13-7-5-11-32(30)37;3-2(4,5)1(6)7/h1-13,25-26,28,34-36,45-47H,14-24H2,(H2,44,56)(H,48,52)(H,49,53)(H,50,54)(H,51,55);(H,6,7)/t34-,35+,36+;/m0./s1 |
| InChIKey | YKEWFQMJVBJGEJ-GTKQDQPASA-N |
| SMILES | C1CNCCC1C(=O)N[C@H](CC2=CSC3=CC=CC=C32)C(=O)N[C@H](CC4=CNC5=CC=CC=C54)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)NC7(CCNCC7)C(=O)N.C(=O)(C(F)(F)F)O |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
